These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21092007)

  • 41. Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
    Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Sachanas S; Angelopoulou MK
    Leuk Lymphoma; 2014 Jul; 55(7):1463-70. PubMed ID: 24050506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. State-of-the-art therapeutics: marginal-zone lymphoma.
    Bertoni F; Zucca E
    J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
    Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An insidious presentation of splenic marginal zone lymphoma.
    Burcheri S; Arcaini L; Della Porta M; Paulli M; Boveri E; Zibellini S; Rumi E; Algarotti A; Passamouti F; Lazzarino M
    Clin Lymphoma Myeloma; 2007 May; 7(6):432-3. PubMed ID: 17621411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current management of marginal zone lymphomas].
    Bonnet C; Lejeune M; Van Kemseke C; Bron D; Beguin Y
    Rev Med Suisse; 2015 Aug; 11(483):1549-56. PubMed ID: 26502581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011).
    Eberle N; von Babo V; Nolte I; Baumgärtner W; Betz D
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):250-60. PubMed ID: 22911256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Splenic marginal zone lymphoma].
    Dimopoulos K; Pedersen M
    Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrated analysis of transcriptome, methylome and copy number aberrations data of marginal zone lymphoma and follicular lymphoma in dog.
    Giannuzzi D; Giudice L; Marconato L; Ferraresso S; Giugno R; Bertoni F; Aresu L
    Vet Comp Oncol; 2020 Dec; 18(4):645-655. PubMed ID: 32154977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.
    Teske E; Rutteman GR; Kirpenstein J; Hirschberger J
    Vet Comp Oncol; 2011 Dec; 9(4):283-9. PubMed ID: 22077409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
    Borgatti A; Fieberg A; Winter AL; Stuebner K; Taras E; Todhunter D; Masyr A; Rendhal A; Vallera DA; Koopmeiners JS; Modiano JF
    Vet Comp Oncol; 2020 Dec; 18(4):664-674. PubMed ID: 32187827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary spinal marginal zone lymphoma: case report and review of the literature.
    Ahmadi SA; Frank S; Hänggi D; Eicker SO
    Neurosurgery; 2012 Aug; 71(2):E495-508; discussion E508. PubMed ID: 22314752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings.
    Behdad A; Bailey NG
    Arch Pathol Lab Med; 2014 Oct; 138(10):1295-301. PubMed ID: 25268192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Splenic marginal zone lymphomas of mice.
    Fredrickson TN; Lennert K; Chattopadhyay SK; Morse HC; Hartley JW
    Am J Pathol; 1999 Mar; 154(3):805-12. PubMed ID: 10079258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Observation of the Progression From Nodal Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma in a Dog.
    Shiga T; Chambers JK; Sugawara M; Goto-Koshino Y; Tsujimoto H; Nakayama H; Uchida K
    Vet Pathol; 2020 Jul; 57(4):520-524. PubMed ID: 32608349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ; Ali S
    Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Morphologic, immunohistochemical, and molecular characterization of hepatosplenic T-cell lymphoma in a dog.
    Cienava EA; Barnhart KF; Brown R; Mansell J; Dunstan R; Credille K
    Vet Clin Pathol; 2004; 33(2):105-10. PubMed ID: 15195270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial Gastrectomy at the Time of Splenectomy in Two Dogs With Splenic Neoplasia and Gastric Involvement.
    Montinaro V; Chiti LE; Rossi N; Massari F; Romanelli G
    Top Companion Anim Med; 2021 Mar; 42():100487. PubMed ID: 33115688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
    Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
    Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.